PHARMACRISTINE

Indicated in acute leukemia, combination with other anticancer agents in Hodgkin’s disease, non–Hodgkin’s malignant lymphomas, rhabdomyosarcoma, neuroblastoma, and Wilms’ tumor.

Dosage Forms:

1 mg, 2 mg